Search research articles
Contact Us
Filters
Showing results (11-20 of 390) with videos related to
Page
of 39
Sort By:
Fundamental & Clinical Pharmacology
|
February 7, 2003
Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs
Annick Rousseau, Pierre Marquet
Expert Opinion on Drug Metabolism & Toxicology
|
March 26, 2011
The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation
Nicolas Picard, Pierre Marquet
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 20, 2004
In vitro study of mycophenolic acid glucuronidation
Nicolas Picard, Pierre Marquet
Bulletin Du Cancer
|
November 14, 2008
[Pharmacokinetics and therapeutic drug monitoring of anticancer agents]
Pierre Marquet, Annick Rousseau
Clinical Pharmacokinetics
|
August 21, 2009
Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I
Caroline Monchaud, Pierre Marquet
Clinical Pharmacokinetics
|
August 27, 2009
Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part II
Caroline Monchaud, Pierre Marquet
Methods in Molecular Biology (Clifton, N.J.)
|
July 7, 2012
LC-MS/MS screen for xenobiotics and metabolites
François-Ludovic Sauvage, Pierre Marquet
Analytical and Bioanalytical Chemistry
|
January 29, 2010
ESI-MS-MS library of 1,253 compounds for application in forensic and clinical toxicology
François-Ludovic Sauvage, Pierre Marquet
Optics Express
|
August 20, 2010
Real time, nanometric 3D-tracking of nanoparticles made possible by second harmonic generation digital holographic microscopy
Etienne Shaffer, Pierre Marquet, Christian Depeursinge
Clinical Biochemistry
|
March 16, 2005
LC-MS/MS systematic toxicological analysis: comparison of MS/MS spectra obtained with different instruments and settings
Robert Jansen, Gérard Lachatre, Pierre Marquet
Page
of 39
Search research articles
Search
Showing results (11-20 of 390) with videos related to
Sort By:
Page
of 39
Fundamental & Clinical Pharmacology
|
February 7, 2003
Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs
Annick Rousseau, Pierre Marquet
Expert Opinion on Drug Metabolism & Toxicology
|
March 26, 2011
The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation
Nicolas Picard, Pierre Marquet
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 20, 2004
In vitro study of mycophenolic acid glucuronidation
Nicolas Picard, Pierre Marquet
Bulletin Du Cancer
|
November 14, 2008
[Pharmacokinetics and therapeutic drug monitoring of anticancer agents]
Pierre Marquet, Annick Rousseau
Clinical Pharmacokinetics
|
August 21, 2009
Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I
Caroline Monchaud, Pierre Marquet
Clinical Pharmacokinetics
|
August 27, 2009
Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part II
Caroline Monchaud, Pierre Marquet
Methods in Molecular Biology (Clifton, N.J.)
|
July 7, 2012
LC-MS/MS screen for xenobiotics and metabolites
François-Ludovic Sauvage, Pierre Marquet
Analytical and Bioanalytical Chemistry
|
January 29, 2010
ESI-MS-MS library of 1,253 compounds for application in forensic and clinical toxicology
François-Ludovic Sauvage, Pierre Marquet
Optics Express
|
August 20, 2010
Real time, nanometric 3D-tracking of nanoparticles made possible by second harmonic generation digital holographic microscopy
Etienne Shaffer, Pierre Marquet, Christian Depeursinge
Clinical Biochemistry
|
March 16, 2005
LC-MS/MS systematic toxicological analysis: comparison of MS/MS spectra obtained with different instruments and settings
Robert Jansen, Gérard Lachatre, Pierre Marquet
Page
of 39